Xunfei Healthcare Technology Co., Ltd.
Xunfei Healthcare Technology Co., Ltd. (HKSE: 2506) is trading at HK$63.30, about ₹775 at today's HKD/INR rate, as of 28 Sep 2026, 4:08 AM ET, down 3.21% today. Indian residents can buy Xunfei Healthcare Technology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$63.10
Today's high
HK$64.70
52 week low
HK$62.20
52 week high
HK$134.10
2506 opened at HK$63.95, closed previously at HK$65.40, and has traded between HK$62.20 and HK$134.10 over the past 52 weeks.
About
Xunfei Healthcare Technology Co., Ltd. provides healthcare AI solutions in the People's Republic of China. The company offers primary solutions, including a general practice clinical decision support system (CDSS) and chronic disease management, which enables identification of key populations, one-click chronic disease screening and risk stratification, dynamic health monitoring, smart task reminders, and decision support during service delivery. It also offers smart hospital solutions, including smart service, smart healthcare, smart medical treatment combination, as well as the iFlytek Xiaoyi APP, an AI health assistant. In addition, the company provides regional public health solutions and medical insurance administrative solutions. Further, the company provides the Xunfei Xiaoyi APP, an AI-driven post-discharge patient management system, and the Cloud Medical Imaging Platform, which offers remote consultation services; and digital imaging services. Additionally, it offers intelligent healthcare solutions, including a general practitioner assistant, grass-roots integrated intelligent information platform, family physician assistant, AI chronic disease management system, and a smart surveillance and early warning platform for infectious diseases. The company's intelligent hardware offerings include smart hearing aids and a smart sphygmomanometer. The company was formerly known as Anhui Xunfei Medical Co., Ltd. and changed its name to Xunfei Healthcare Technology Co., Ltd. in February 2023. The company was founded in 2016 and is headquartered in Hefei, the People's Republic of China.
Key statistics
Avg. volume
130.41K
Market cap
HK$4.89B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
1.84
Dividend yield
—
Last dividend
HK$0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Xunfei Healthcare Technology from India
Indian residents can buy Xunfei Healthcare Technology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Xunfei Healthcare Technology and place an order
Find Xunfei Healthcare Technology by name or by its ticker, 2506, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Xunfei Healthcare Technology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Xunfei Healthcare Technology position in HKD and INR. Xunfei Healthcare Technology pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Xunfei Healthcare Technology from India
Trading and taxes when buying Xunfei Healthcare Technology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneXunfei Healthcare Technology does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Xunfei Healthcare Technology stock?
Yes. Xunfei Healthcare Technology (2506) has been listed on the Hong Kong Stock Exchange since 2024, in the Medical - Healthcare Information Services industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Xunfei Healthcare Technology share cost in rupees?
One Xunfei Healthcare Technology share is HK$63.30 — about ₹775 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the Xunfei Healthcare Technology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Xunfei Healthcare Technology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Xunfei Healthcare Technology?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Xunfei Healthcare Technology shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Xunfei Healthcare Technology price. Paasa issues a capital-gains statement for your return.
Does Xunfei Healthcare Technology pay a dividend?
No. Xunfei Healthcare Technology does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Xunfei Healthcare Technology from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Xunfei Healthcare Technology a Hong Kong SAR China company, and does that change how it is taxed?
Xunfei Healthcare Technology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Xunfei Healthcare Technology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Xunfei Healthcare Technology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Xunfei Healthcare Technology holding, its cost and its closing value.
How do I sell Xunfei Healthcare Technology and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.